Matricelf Ltd (MTLF) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Matricelf Ltd (MTLF) has a cash flow conversion efficiency ratio of -997.589x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-8.28 Million ≈ $-22.18K USD) by net assets (ILA8.29K ≈ $22.24 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Matricelf Ltd - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Matricelf Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Matricelf Ltd (MTLF) total liabilities for a breakdown of total debt and financial obligations.
Matricelf Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Matricelf Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
PODIUM MINERALS
F:55D
|
N/A |
|
System and Application Technologies Co. Ltd
KQ:060540
|
0.023x |
|
ChemX Materials Ltd
AU:CMX
|
0.416x |
|
Desane Group Holdings Ltd
AU:DGH
|
0.000x |
|
Korea SE Corp
KQ:101670
|
-0.024x |
|
Hawthorn Resources Ltd
AU:HAW
|
-0.019x |
|
Seafresh Industry Public Company Limited
BK:CFRESH
|
0.070x |
|
ProMIS Neurosciences Inc.
NASDAQ:PMN
|
-1.108x |
Annual Cash Flow Conversion Efficiency for Matricelf Ltd (2019–2024)
The table below shows the annual cash flow conversion efficiency of Matricelf Ltd from 2019 to 2024. For the full company profile with market capitalisation and key ratios, see MTLF market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ILA15.17 Million ≈ $40.66K |
ILA-11.75K ≈ $-31.51 |
-0.001x | -98.09% |
| 2023-12-31 | ILA26.80 Million ≈ $71.86K |
ILA-10.49K ≈ $-28.12 |
0.000x | +99.83% |
| 2022-12-31 | ILA35.79 Million ≈ $95.96K |
ILA-8.30 Million ≈ $-22.25K |
-0.232x | +8.20% |
| 2021-12-31 | ILA26.23 Million ≈ $70.32K |
ILA-6.62 Million ≈ $-17.76K |
-0.253x | +79.57% |
| 2020-12-31 | ILA2.80 Million ≈ $7.50K |
ILA-3.46 Million ≈ $-9.27K |
-1.236x | -1354.61% |
| 2019-12-31 | ILA3.62 Million ≈ $9.71K |
ILA-307.80K ≈ $-825.19 |
-0.085x | -- |
About Matricelf Ltd
Matricelf Ltd, a biotechnology company, develops a platform for autologous tissue engineering for various medical conditions. The company's regenerative medicine platform intends to cure a range of medical conditions, including spinal cord injuries, age-related macular degeneration, Parkinson's disease, and myocardial infarction, as well as for 3D bioprinting. Matricelf Ltd was incorporated in 20… Read more